Medical ethicists have discussed the use of race classification in determining disease prevalence and the response of specific ethnic groups to different medications.
A recent journal article calls for a public policy that would require physician-researchers to demonstrate the absence of undue influence or coercion on informed consent.
When patients and physicians disagree on the use of genetic engineering technology, physicians must act in accordance with professional ethics and society's guidelines.